Market Research Reports and Industry Reports
instagram takipci kasma instagram takipci kasma atasehir escort maltepe escort kurtkoy escort maltepe escort alanya escort antalya escort konya escort tuzla escort pendik escort bostanci escort atasehir escort kadikoy escort kurtkoy escort tuzla escort erenkoy escort beykoz escort umraniye escort

Dengue Fever - Pipeline Review, H2 2017

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Dengue Fever - Pipeline Review, H2 2017

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever - Pipeline Review, H2 2017, provides an overview of the Dengue Fever (Infectious Disease) pipeline landscape.

Dengue is a mosquito borne infectious disease caused by the dengue virus. Symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. In some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from nose, gums, or under skin. It can also become dengue shock syndrome, which causes massive bleeding and shock. Treatment includes use of analgesics, fluid replacement therapy and healthy life style.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Dengue Fever - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Dengue Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Dengue Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Dengue Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 2, 6, 27, 19 and 2 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 2, 1, 4, 11 and 12 molecules, respectively.

Dengue Fever (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Dengue Fever (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Dengue Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Dengue Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Dengue Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Dengue Fever (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Dengue Fever (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Dengue Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2
Introduction 4
Dengue Fever - Overview 5
Dengue Fever - Therapeutics Development 6
Dengue Fever - Therapeutics Assessment 19
Dengue Fever - Companies Involved in Therapeutics Development 27
Dengue Fever - Drug Profiles 41
Dengue Fever - Dormant Projects 141
Dengue Fever - Discontinued Products 145
Dengue Fever - Product Development Milestones 146
Appendix 156

List Of Tables


Number of Products under Development for Dengue Fever, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017
Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Products under Development by Universities/Institutes, H2 2017
Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Dengue Fever - Pipeline by Abivax SA, H2 2017
Dengue Fever - Pipeline by Altravax Inc, H2 2017
Dengue Fever - Pipeline by Biological Mimetics Inc, H2 2017
Dengue Fever - Pipeline by Bioneer Corp, H2 2017
Dengue Fever - Pipeline by Biotron Ltd, H2 2017
Dengue Fever - Pipeline by Chugai Pharmaceutical Co Ltd, H2 2017
Dengue Fever - Pipeline by Emergent BioSolutions Inc, H2 2017
Dengue Fever - Pipeline by Ennaid Therapeutics LLC, H2 2017
Dengue Fever - Pipeline by GeneSegues Inc, H2 2017
Dengue Fever - Pipeline by GlaxoSmithKline Plc, H2 2017
Dengue Fever - Pipeline by Globavir Biosciences Inc, H2 2017
Dengue Fever - Pipeline by Hawaii Biotech Inc, H2 2017
Dengue Fever - Pipeline by Immunotope Inc, H2 2017
Dengue Fever - Pipeline by Indian Immunologicals Ltd, H2 2017
Dengue Fever - Pipeline by Inovio Pharmaceuticals Inc, H2 2017
Dengue Fever - Pipeline by Johnson & Johnson, H2 2017
Dengue Fever - Pipeline by Kineta Inc, H2 2017
Dengue Fever - Pipeline by Merck & Co Inc, H2 2017
Dengue Fever - Pipeline by Novartis AG, H2 2017
Dengue Fever - Pipeline by NovaTarg Therapeutics Inc, H2 2017
Dengue Fever - Pipeline by Panacea Biotec Ltd, H2 2017
Dengue Fever - Pipeline by Plex Pharmaceuticals Inc, H2 2017
Dengue Fever - Pipeline by Shionogi & Co Ltd, H2 2017
Dengue Fever - Pipeline by SIGA Technologies Inc, H2 2017
Dengue Fever - Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2017
Dengue Fever - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2017
Dengue Fever - Pipeline by TechnoVax Inc, H2 2017
Dengue Fever - Pipeline by Themis Bioscience GmbH, H2 2017
Dengue Fever - Pipeline by Visterra Inc, H2 2017
Dengue Fever - Pipeline by VLP Therapeutics LLC, H2 2017
Dengue Fever - Dormant Projects, H2 2017
Dengue Fever - Dormant Projects, H2 2017 (Contd..1), H2 2017
Dengue Fever - Dormant Projects, H2 2017 (Contd..2), H2 2017
Dengue Fever - Dormant Projects, H2 2017 (Contd..3), H2 2017
Dengue Fever - Discontinued Products, H2 2017

List Of Figures


Number of Products under Development for Dengue Fever, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Top 10 Molecule Types, H2 2017
Number of Products by Stage and Top 10 Molecule Types, H2 2017

Dengue Fever - Pipeline Review, H2 2017

Dengue Fever - Pipeline Review, H2 2017Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever - Pipeline Review, H2 2017, provides an overview of the Dengue Fever

USD 2000View Report

Asia-Pacific Dengue Virus Diagnostic Tests Market Report 2017

In this report, the Asia-Pacific Dengue Virus Diagnostic Tests market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of

USD 4000View Report

Q Fever - Pipeline Review, H2 2017

Q Fever - Pipeline Review, H2 2017Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Q Fever - Pipeline Review, H2 2017, provides an overview of the Q Fever

USD 2000View Report

Typhoid Fever - Pipeline Insight, 2017

DelveInsights, Typhoid Fever-Pipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Typhoid Fever. The report provides a complete understanding of the pipeline activities covering

USD 1250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 2000
  • Site Licence    USD 4000
  • Enterprise Wide Licence    USD 6000
$ 2000

Reports Details

Published Date : Dec 2017
No. of Pages :166
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
Copyright © 2008 - 2018 Aarkstore.com | All rights reserved.